Is ‘The Trip’ Essential to The Psychedelic Experience?

Is ‘The Trip’ Essential to The Psychedelic Experience?

Biology and experience are tough to separate, but some researchers are exploring the possibility of non-hallucinogenic psychedelics as a mental health treatment. This begs the question: what do we lose, and what do we gain when we take the trip out of the psychedelic experience?
Psychedelics Can Change Your View on the Nature of Reality

Psychedelics Can Change Your View on the Nature of Reality

A recent study has found that psychedelics can fundamentally change your core beliefs about the nature of fate, reality, and consciousness.

Texas Further Embraces Psychedelics with Launch of Center for Psychedelic Research and Therapy

Research will focus on how various psychedelics can be used under proper supervision and guidance to treat severe depression, anxiety and PTSD.
FDA Green Lights Tryp Therapeutics' Psilocybin Study on Binge Eating DisorderShutterstock.com

FDA Green Lights Tryp Therapeutics’ Psilocybin Study on Binge Eating Disorder

The pharmaceutical company developing psilocybin-based compounds for diseases with unmet medical needs estimates a $2.9 billion market potential for such a treatment.

Understanding HPPD to Prioritize Harm Reduction of a Very Real Psychedelic Risk

“HPPD is precisely the kind of risk that could fall through the cracks," says journalist Ed Prideaux, who suffers from the condition and advocates for more research.

Compass Pathways Study Finds SSRI Drugs Did Not Impede Psilocybin’s Therapeutic Effect

Chief Medical Officer Guy Goodwin calls study "a strong signal that COMP360 psilocybin therapy could be an adjunctive treatment to SSRI antidepressant as well as a monotherapy."
Non-Hallucinogenic DMT? Psilera Bioscience Reports Progress on 'Well-Tolerated' Derivative

Non-Hallucinogenic DMT? Psilera Bioscience Reports Progress on ‘Well-Tolerated’ Derivative

,
Further in vivo studies with PSIL-002 will evaluate its antidepressant, anxiolytic, and anti-addictive properties, specifically targeting alcohol consumption.
You Can Make ‘Bad Trips’ Good with Storytelling, Study Shows

You Can Make ‘Bad Trips’ Good with Storytelling, Psychedelics Study Shows

Evidence supports the idea that the possibly unpleasant nature of the psychedelic experience is an integral part of its therapeutic benefits.
Microdosing Psilocybin and LSD Rises During Pandemic, Global Drug Survey FindsShutterstock.com

Microdosing LSD and Psilocybin Rises During Pandemic, Global Drug Survey Finds

The report also explores how microdosing may impact the use of other prescribed mental health medications.

Can Psychedelics Cure Chronic Pain? This Promising Study Lays Groundwork for Future Clinical Trials

Nine out of the 11 chronic pain sufferers interviewed say they experienced some kind of lasting pain reduction while self-medicating with psychedelics.